Clinical trials recruiting in Bergisch Gladbach, Germany
8
Recruiting trials
14
Conditions
Phase breakdown
Phase 2 1Phase 3 4Not applicable 3
Conditions recruiting in Bergisch Gladbach, Germany
Recruiting trials in Bergisch Gladbach, Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- PROCARE - PROstate Cancer Real World Evidence Registry
- Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
Common questions
How many clinical trials are recruiting in Bergisch Gladbach, Germany?
8 recruiting trials have at least one study site in Bergisch Gladbach, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.